DIVIS LABORATORIES
|
The Current P/S Ratio of DIVIS LABORATORIES is 19.25.
Share Price | ₹6,785.4 | Jul 17,2025 |
Market Cap | ₹180,152.4 Cr | |
Sales-TTM | ₹9,360.0 Cr | TTM-Consolidated Results |
Price/Sales | 19.25x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of DIVIS LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹180,152.4 Cr] as on Jul 17,2025
(/) Sales [ ₹9,360.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 19.25x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay '19.25 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of DIVIS LABORATORIES !
The chart below summarizes the trend in P/S Ratio of DIVIS LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of DIVIS LABORATORIES
PS Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.89x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 13.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 16.34x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 9.64x.
How does DIVIS LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
DIVIS LABORATORIES | 9,360.0 | 19.25 | 180,152.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.77 | 408,667.0 |
CIPLA LTD | 27,547.6 | 4.35 | 119,745.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 10.30 | 118,603.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.23 | 105,429.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.88 | 108,985.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.25 | 98,812.2 |
LUPIN LTD | 22,707.9 | 3.93 | 89,310.1 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.11 | 67,021.6 |
ABBOTT INDIA LTD | 6,409.2 | 11.32 | 72,520.4 |
ALKEM LABORATORIES LTD | 12,964.5 | 4.62 | 59,948.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs DIVIS LABORATORIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.11x |
Max industry PS | 19.25x |
Median industry PS | 4.62x |
Average industry PS | 7.27x |
You may also like the below Video Courses